Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

December 2014 Archives

Propecia injury attracts international interest

The study of sexual dysfunction linked to the use of the male pattern hair loss drug Propecia has been spreading globally, according to the growing number of nations whose surfers have pointed their web browsers at a U.S.-based source of information. While this has been going on, a growing number of injured patients have filed Propecia lawsuits.

Propecia injury attracts international interest

The study of sexual dysfunction linked to the use of the male pattern hair loss drug Propecia has been spreading globally, according to the growing number of nations whose surfers have pointed their web browsers at a U.S.-based source of information. While this has been going on, a growing number of injured patients have filed Propecia lawsuits.

Let's hope Actos, Januvia history is not repeated

The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.

Let's hope Actos, Januvia history is not repeated

The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.

Panel may centralize Lipitor lawsuits

Litigants in Lipitor product liability lawsuits, precisely the type of people we fight for here at Reich & Binstock, may see their cases transferred to the U.S. District Court for the Southern District of South Carolina. The panel took up at its Feb. 6 hearing a motion to consolidate before one federal trial court Lipitor lawsuits from a dozen states.

Panel may centralize Lipitor lawsuits

Litigants in Lipitor product liability lawsuits, precisely the type of people we fight for here at Reich & Binstock, may see their cases transferred to the U.S. District Court for the Southern District of South Carolina. The panel took up at its Feb. 6 hearing a motion to consolidate before one federal trial court Lipitor lawsuits from a dozen states.

Metal-on-Metal hip implant patients deserved better

The experienced attorneys at Reich & Binstock represent clients in metal-on-metal hip implant lawsuits whose experiences demonstrate the futility of presumably good intentions. Recently, medical science has validated the pain and suffering of many metal-on-metal hip implant patients who experienced a prosthesis failure.

Metal-on-Metal hip implant patients deserved better

The experienced attorneys at Reich & Binstock represent clients in metal-on-metal hip implant lawsuits whose experiences demonstrate the futility of presumably good intentions. Recently, medical science has validated the pain and suffering of many metal-on-metal hip implant patients who experienced a prosthesis failure.

First Zoloft, then Effexor

Effexor and Zoloft are not in the same pharmacological class of antidepressants. Nevertheless, they share a distinction in the eyes of the law. The manufacturer of both drugs is defending itself from product liability litigation that a federal judicial panel centralized for pretrial proceedings before the U.S. District Court for the Eastern District of Pennsylvania.

First Zoloft, then Effexor

Effexor and Zoloft are not in the same pharmacological class of antidepressants. Nevertheless, they share a distinction in the eyes of the law. The manufacturer of both drugs is defending itself from product liability litigation that a federal judicial panel centralized for pretrial proceedings before the U.S. District Court for the Eastern District of Pennsylvania.

Risperdal potentially damaging to male youth

The Journal of Child and Adolescent Psychopharmacology in its December 2012 issue revealed a study that examined males ages 10-20 who were taking the Johnson & Johnson antipsychotic Risperdal (risperidone) and those of the same ages who took no antipsychotic. Researchers discovered that hyperprolactinemia, or excess prolactin, "is a common side effect in young males treated over the long term with risperidone."

Risperdal potentially damaging to male youth

The Journal of Child and Adolescent Psychopharmacology in its December 2012 issue revealed a study that examined males ages 10-20 who were taking the Johnson & Johnson antipsychotic Risperdal (risperidone) and those of the same ages who took no antipsychotic. Researchers discovered that hyperprolactinemia, or excess prolactin, "is a common side effect in young males treated over the long term with risperidone."

FDA lowers boom on two diet drugs

Prescription drugs are not the only drugs that can be marketed despite their increased risks of harm to anyone who uses them. The U.S. Food and Drug Administration on Jan. 22 urged consumers not to use two diet concoctions because they contained substances that have been linked to increased risks of injury.

FDA lowers boom on two diet drugs

Prescription drugs are not the only drugs that can be marketed despite their increased risks of harm to anyone who uses them. The U.S. Food and Drug Administration on Jan. 22 urged consumers not to use two diet concoctions because they contained substances that have been linked to increased risks of injury.

Group calls for black box warning on testosterone

The advocacy group Public Citizen on Feb. 25 petitioned the U.S. Food and Drug Administration to require a black box warning on testosterone products. The call was based on recent studies that link the use of those drugs to an increased risk of heart attack and other cardiovascular disorders.

Group calls for black box warning on testosterone

The advocacy group Public Citizen on Feb. 25 petitioned the U.S. Food and Drug Administration to require a black box warning on testosterone products. The call was based on recent studies that link the use of those drugs to an increased risk of heart attack and other cardiovascular disorders.

Pradaxa lawsuits uncover manufacturer cover-up

Reportedly, Boehringer Ingelheim, the maker of the blood thinner Pradaxa, had two sets of data about the safety of its drug, concealing from the U.S. Food and Drug Administration the one that showed a heightened level of fatal bleeding associated with using the drug. The conclusion comes from the release of the pharmaceutical corporation's internal documents in connection with Pradaxa lawsuits.

Pradaxa lawsuits uncover manufacturer cover-up

Reportedly, Boehringer Ingelheim, the maker of the blood thinner Pradaxa, had two sets of data about the safety of its drug, concealing from the U.S. Food and Drug Administration the one that showed a heightened level of fatal bleeding associated with using the drug. The conclusion comes from the release of the pharmaceutical corporation's internal documents in connection with Pradaxa lawsuits.

Multidistrict Litigation Court set up for Lipitor lawsuits

The U.S. Judicial Panel on Multidistrict Litigation in February centralized Lipitor lawsuits filed in federal court. One judge will oversee consolidated pre-trial proceedings for those Lipitor lawsuits placed before one multidistrict litigation court, the U.S. District Court for the District of South Carolina.

Multidistrict Litigation Court set up for Lipitor lawsuits

The U.S. Judicial Panel on Multidistrict Litigation in February centralized Lipitor lawsuits filed in federal court. One judge will oversee consolidated pre-trial proceedings for those Lipitor lawsuits placed before one multidistrict litigation court, the U.S. District Court for the District of South Carolina.

GranuFlo lawsuit court gets more cases

More than 500 GranuFlo lawsuits have been consolidated for the sake of pretrial uniformity before the U.S. District Court for the District of Massachusetts. The U.S. Judicial Panel on Multidistrict Litigation, the body that centralizes cases in this manner, transferred five cases there against plaintiffs' motions from the federal districts of Central California, Southern California and South Carolina.

GranuFlo lawsuit court gets more cases

More than 500 GranuFlo lawsuits have been consolidated for the sake of pretrial uniformity before the U.S. District Court for the District of Massachusetts. The U.S. Judicial Panel on Multidistrict Litigation, the body that centralizes cases in this manner, transferred five cases there against plaintiffs' motions from the federal districts of Central California, Southern California and South Carolina.

Medical journal reiterates Topamax birth defects risk

The February 2014 edition of the neurology journal Continuum published a review of the issues centered on the medical management of women with epilepsy. The article reiterated the increased risks of birth defects associated with a woman's use of antiepileptic drugs while pregnant.

Medical journal reiterates Topamax birth defects risk

The February 2014 edition of the neurology journal Continuum published a review of the issues centered on the medical management of women with epilepsy. The article reiterated the increased risks of birth defects associated with a woman's use of antiepileptic drugs while pregnant.

Transvaginal mesh lawsuits into tens of thousands

One could never tell from the volume of litigation that there has not been one recall after another of a transvaginal mesh. In the federal courts alone, as of March 13, 43,173 transvaginal mesh lawsuits filed against seven manufacturers were centralized before the U.S. District Court for the Southern District of West Virginia.

Transvaginal mesh lawsuits into tens of thousands

One could never tell from the volume of litigation that there has not been one recall after another of a transvaginal mesh. In the federal courts alone, as of March 13, 43,173 transvaginal mesh lawsuits filed against seven manufacturers were centralized before the U.S. District Court for the Southern District of West Virginia.

Justice for Galveston Bay oil spill victims

Hundreds of thousands of gallons of fuel oil were released into Galveston Bay in March 2014 after a barge collided with a tanker. Property was damaged. Livelihoods suffered setbacks. People who depend on the seafood industry, people whose businesses serve beach goers, and many others may be entitled to compensation as a result of the financially suffocating fallout.

Justice for Galveston Bay oil spill victims

Hundreds of thousands of gallons of fuel oil were released into Galveston Bay in March 2014 after a barge collided with a tanker. Property was damaged. Livelihoods suffered setbacks. People who depend on the seafood industry, people whose businesses serve beach goers, and many others may be entitled to compensation as a result of the financially suffocating fallout.

Harmed by Yaz? An experienced attorney can help

An experienced attorney from the law firm of Reich & Binstock, which operates in all 50 states, can be a valuable asset to a plaintiff involved in a product liability lawsuit against a corporate behemoth. In litigation centered on the side effects of the combination oral contraceptive Yaz/Yasmin, one plaintiff's plight is a sobering reminder of what a difference an attorney can make.

Harmed by Yaz? An experienced attorney can help

An experienced attorney from the law firm of Reich & Binstock, which operates in all 50 states, can be a valuable asset to a plaintiff involved in a product liability lawsuit against a corporate behemoth. In litigation centered on the side effects of the combination oral contraceptive Yaz/Yasmin, one plaintiff's plight is a sobering reminder of what a difference an attorney can make.

Panel may transfer nearly 100 Lipitor lawsuits

Nearly 100 diabetic plaintiffs in Lipitor lawsuits, more than 80 of which from the federal Central District of California, will find out in June whether their cases will be adjudicated in the courts in which those lawsuits were filed. The U.S. Judicial Panel on Multidistrict Litigation will rule after its May 29 hearing in Chicago on whether plaintiffs' opposition to transferring these Lipitor lawsuits is just.

Panel may transfer nearly 100 Lipitor lawsuits

Nearly 100 diabetic plaintiffs in Lipitor lawsuits, more than 80 of which from the federal Central District of California, will find out in June whether their cases will be adjudicated in the courts in which those lawsuits were filed. The U.S. Judicial Panel on Multidistrict Litigation will rule after its May 29 hearing in Chicago on whether plaintiffs' opposition to transferring these Lipitor lawsuits is just.

FDA proposes expedited medical device approvals

There are countless U.S. patients who suffer from life-threatening conditions and whose survival depends upon the timely introduction of a medical device that might work and, then again, might not. The U.S. Food and Drug Administration wants to give hope to the seeming hopeless by expediting the approval of so-called high-risk medical devices. The agency thusly proposed and opened up for public comment, the Expedited Access Premarket Approval Application or EAP.

FDA proposes expedited medical device approvals

There are countless U.S. patients who suffer from life-threatening conditions and whose survival depends upon the timely introduction of a medical device that might work and, then again, might not. The U.S. Food and Drug Administration wants to give hope to the seeming hopeless by expediting the approval of so-called high-risk medical devices. The agency thusly proposed and opened up for public comment, the Expedited Access Premarket Approval Application or EAP.

The compensable risks of Mirena

Eight more Mirena IUD lawsuits may be transferred from Illinois, Louisiana, Missouri and Mississippi courts to the U.S. District Court for the Southern District of New York. But if the defendant, Bayer, and the plaintiffs have anything to do with it, those cases will stay put.

The compensable risks of Mirena

Eight more Mirena IUD lawsuits may be transferred from Illinois, Louisiana, Missouri and Mississippi courts to the U.S. District Court for the Southern District of New York. But if the defendant, Bayer, and the plaintiffs have anything to do with it, those cases will stay put.

FDA proposes transvaginal mesh safety measures

Although it has not coerced a recall of the transvaginal mesh surgical device, the U.S. Food and Drug Administration has proposed measures that were intended to improve patient safety. The proposals were introduced in April while more than 40,000 federal transvaginal mesh lawsuits filed against seven different manufacturers were consolidated before the U.S. District Court for the Southern District of West Virginia.

FDA proposes transvaginal mesh safety measures

Although it has not coerced a recall of the transvaginal mesh surgical device, the U.S. Food and Drug Administration has proposed measures that were intended to improve patient safety. The proposals were introduced in April while more than 40,000 federal transvaginal mesh lawsuits filed against seven different manufacturers were consolidated before the U.S. District Court for the Southern District of West Virginia.

Infusion pump can fail when used with docking station

The U.S. Food and Drug Administration announced earlier this month that Hospira Inc. would recall its Gemstar Docking Station due to a problem that has the potential to adversely affect the user of the Gemstar infusion pump. The FDA categorized it as the highest and most urgent level of recall because of the safety concern.

Infusion pump can fail when used with docking station

The U.S. Food and Drug Administration announced earlier this month that Hospira Inc. would recall its Gemstar Docking Station due to a problem that has the potential to adversely affect the user of the Gemstar infusion pump. The FDA categorized it as the highest and most urgent level of recall because of the safety concern.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions